| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |